Literature DB >> 16756628

Current status of dosing and quantification of acute renal replacement therapy. Part 1: mechanisms and consequences of therapy under-delivery.

Mark R Marshall1.   

Abstract

The dosing and quantification of acute renal replacement therapy has emerged as one of the most pressing issues in the management of critically-ill patients with acute kidney injury. Although there is ongoing debate as to the best marker of uraemic injury in this setting, several landmark studies have identified clearance-related expressions of acute renal replacement therapy dose as important determinants of survival. Part 1 of this review examines the factors affecting delivery of prescribed acute renal replacement therapy dose. The review continues in Part 2 and examines the implications of recent advances in this area for clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756628     DOI: 10.1111/j.1440-1797.2006.00572.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

Review 1.  Effluent volume and dialysis dose in CRRT: time for reappraisal.

Authors:  Etienne Macedo; Rolando Claure-Del Granado; Ravindra L Mehta
Journal:  Nat Rev Nephrol       Date:  2011-11-01       Impact factor: 28.314

2.  Solute clearance in CRRT: prescribed dose versus actual delivered dose.

Authors:  William D Lyndon; Keith M Wille; Ashita J Tolwani
Journal:  Nephrol Dial Transplant       Date:  2011-09-05       Impact factor: 5.992

3.  Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Glenn M Chertow; Sharon Soroko; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

4.  Toward the optimal dose metric in continuous renal replacement therapy.

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Glenn M Chertow; Sharon Soroko; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Int J Artif Organs       Date:  2012-06       Impact factor: 1.595

5.  Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Sharon Soroko; YeonWon Kim; Glenn M Chertow; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Hemodial Int       Date:  2014-03-12       Impact factor: 1.812

Review 6.  Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.

Authors:  Enzo Vásquez Jiménez; Samaya J Anumudu; Javier A Neyra
Journal:  Nephron       Date:  2021-02-04       Impact factor: 2.847

7.  Clinical outcomes and prognostic factors of mortality in liver cirrhosis patients on continuous renal replacement therapy in two tertiary hospitals in Korea.

Authors:  You Hyun Jeon; Il Young Kim; Gum Sook Jang; Sang Heon Song; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Hyo Jin Kim
Journal:  Kidney Res Clin Pract       Date:  2021-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.